Mortality risk is associated with disease activity in patients with Sjögren disease: a South Australian retrospective cohort study
Year: 2026
Type: article
Study design: Observational Study
Abstract: OBJECTIVES: To evaluate the overall risk of mortality in Sjögren disease (SjD) and its relationship to baseline systemic disease activity in an Australian population. METHODS: This retrospective cohort study included 241 patients fulfilling 2016 ACR-EULAR classification criteria from the South Australian (SA) Sjögren Disease Registry with up to 30 years of follow-up. Baseline data included patient demographics, serology and disease activity (ESSDAI). Analysis included the standardised mortality ratio (SMR) and cox regression. RESULTS: Patients were predominantly female (217, 89%), with a median age at diagnosis of 58 years. Most had oral (99%) and ocular (97%) dryness, Ro/La autoantibodies (193, 80%) and rheumatoid factor (RF, 142, 61%). ESSDAI scores were grouped into low (<5), n = 121 (50%); moderate (5-13), n = 92 (38%); and high (>13), n = 28 (12%). Mortality was not increased compared to the SA population (SMR 1.18, 95%CI 0.90, 1.54). Patients with high baseline ESSDAI disease activity had a four-fold mortality risk compared to patients with low disease activity (HR 3.9, 95%CI 1.7, 8.7). Moderate to high activity in ESSDAI renal or pulmonary domains, and any activity in the biological domain, contributed to this increased mortality. Rheumatoid factor positivity was independently associated with mortality risk (HR 2.2, 95%CI 1.0, 4.7). Causes of death were cardiovascular, pulmonary, infections, cancer, and kidney disease. CONCLUSION: High disease activity at baseline, including moderate to high activity in renal and pulmonary and any activity in biological domain, and positive rheumatoid factor are associated with increased mortality risk in SjD patients, underscoring the systemic impact of this disease.
Source: Rheumatology
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,597
OpenAlex ID: W7236226967
